News

Newsletter

June 1, 2012

  • Kasznar Leonardos

Newsletter 2012.03 – The debate over ANVISA’s role in the examination of pharmaceutical patent applications continues

As you may be aware, due to article 229-C of the Brazilian IP Law, as amended by Law No. 10,196/01, whenever a patent application claims a pharmaceutical product or process, consent from the National Sanitary Surveillance Agency (ANVISA) is also required prior to granting the desired patent. This provision, however, has been the source of never-ending controversy and subject to growing attacks since it entered into effect in 2001.

The lack of statutory power of ANVISA to analyse patentability requirements of pharma applications was supported by the Attorney-General’s Office in legal opinions published in 2009 and 2011. Indeed, in their opinion, ANVISA should only make health-based assessments of applications sent for prior consent; prior consent should only be denied to applications in instances that granting the patents would pose health risks. How ANVISA would assess “health risks” on the basis of the information included in patent applications was left unanswered though.

Back

Last related news

November 25, 2022

FTX Investor Sues Gisele Bündchen And Other Celebrities For Deceptive Practices

The financial collapse of FTX regarded as one of the largest cryptocurrency exchanges in the world brought with it not only financial FTX Investor Sues Gisele Bündchen And Other Celebrities For Deceptive Practices

Ler notícia

November 24, 2022

New Decision From The Brazilian Supreme Court In Favor Of Patent Term Adjustment (PTA) Cases

A new decision from the Brazilian Supreme Court on November 16th brought some hope to patent owners seeking the term adjustment for patents New Decision From The Brazilian Supreme Court In Favor Of Patent Term Adjustment (PTA) Cases

Ler notícia

November 22, 2022

New decision from the Brazilian Supreme Court in favor of Patent Term Adjustment (PTA) cases

A new decision from the Brazilian Supreme Court on November 16th brought some hope to patent owners seeking the term adjustment for patents New decision from the Brazilian Supreme Court in favor of Patent Term Adjustment (PTA) cases

Ler notícia